In 2012, by focusing on a clinical sample consisting of patients with DM and mood disorders, Ceretta et al. (11) demonstrated a high prevalence of depressive disorders, SI, and a poor quality of life in patients with T2DM receiving treatment with insulin. Here, INS is linked to diabetes mellitus.